Horizon Discovery Receives the Queen’s Award for Enterprise in International Trade
Founded in 2007 and based in Cambridge, UK, Horizon has become one of the fastest growing biotechnology companies in Europe. Expanding over 100% in each year of trading, it now has 70 FTE’s working out of its research facility in Cambridge. This growth has been built upon an international customer base that includes over 100 academic research organizations and 100 biotechnology, diagnostic and pharmaceutical companies, using a direct selling and partnership strategy. Greater than 90% of Horizon Discovery sales are currently made into markets outside of the UK, including the USA, Australia, New Zealand, Japan and Singapore. Of the European market, Germany, Switzerland and Austria are Horizon’s primary sources of trade.
Other news from the department business & finance
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.